RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae

Microbial Drug Resistance

Volumn 13, Issue 1, 2007, Pages 1-6

  Keeney, David ^a   Ruzin, Alexey ^a   Bradford, Patricia A ^a  

^a WYETH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; BACTERIAL DNA; CHLORAMPHENICOL; ERYTHROMYCIN; ETHIDIUM BROMIDE; GENE PRODUCT; GENTAMICIN; KANAMYCIN; MINOCYCLINE; NALIDIXIC ACID; NORFLOXACIN; NOVOBIOCIN; PROTEIN RAMA; TETRACYCLINE; TIGECYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ACRA GENE; ACRB GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CORRELATION FUNCTION; ENTEROBACTER CLOACAE; GENE INSERTION; GENE ISOLATION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC COMPLEMENTATION; GRAM NEGATIVE BACTERIUM; MARA GENE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAMA GENE; REGULATOR GENE; STRAIN IDENTIFICATION; TRANSCRIPTION REGULATION; TRANSPOSON;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

BACTERIA (MICROORGANISMS); ENTEROBACTER CLOACAE; NEGIBACTERIA; POSIBACTERIA;

EID: 34249708519     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.9990     Document Type: Article

References (19)

1. Bradford, P.A. 2004. Tigecycline: a first in class glycylcycline. Clin. Microbiol. Newslett. 26:163-168.
2. Chollet, R., C. Bollet, J. Chevalier, M. Mallea, J.M. Pages, and A. Davin-Regli. 2002. mar Operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob. Agents Chemother. 46:1093-1097.
3. Chopra, I. 2002. New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors. Drug Resistance Update 5:119-125.
4. Dean, C.R., M.A. Visalli, S.J. Projan, P.-E. Sum, and P.A. Bradford. 2003. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother. 47:972-978.
5. George, A.M., R.M. Hall, and H.W. Stokes. 1995. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 141(Pt 8):1909-1920.
6. Grkovic, S., M.H. Brown, and R.A. Skurray. 2002. Regulation of bacterial drug export systems. Microbiol. Mol. Biol. Rev. 66:671-701.
7. Jones, C.H., M. Tuckman, A.Y. Howe, M. Orlowski, S. Mullen, K. Chan, and P.A. Bradford. 2006. Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections. Antimicrob. Agents Chemother. 50:505-510.
8. Komatsu, T., M. Ohta, N. Kido, Y. Arakawa, H. Ito, T. Mizuno, and N. Kato. 1990. Molecular characterization of an Enterobacter cloacae gene (romA) which pleiotropically inhibits the expression of Escherichia coli outer membrane proteins. J. Bacteriol. 172:4082-4089.
9. Martin, R.G., W.K. Gillette, S. Rhee, and J.L. Rosner. 1999. Structural requirements for marbox function in transcriptional activation of mar/sox/rob regulon promoters in Escherichia coli: sequence, orientation and spatial relationship to the core promoter. Mol. Microbiol. 34:431-441.
10. McMurry, L.M., M. Oethinger, and S.B. Levy. 1998. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166:305-309.
11. NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standards: M7-A6, Sixth ed, vol. 23. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Petersen, P.J., N.V. Jacobus, W.J. Weiss, P.E. Sum, and R.T. Testa. 1999. In vitro and in vivo antimicrobial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
13. Ruzin, A., D. Keeney, and P.A. Bradford. 2005. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob. Agents Chemother. 49:791-793.
14. Ruzin, A., M.A. Visalli, D. Keeney, and P.A. Bradford. 2005. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother. 49:1017-1022.
15. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
16. Schneiders, T., S.G. Amyes, and S.B. Levy. 2003. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob. Agents Chemother. 47:2831-2837.
17. Schweizer, H.D. 1993. Small broad-host-range gentamicin resistance gene cassettes for site-specific insertion and deletion mutagenesis. Biotechniques 15:831-834.
18. Visalli, M.A., E. Murphy, S.J. Projan, and P.A. Bradford. 2003. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob. Agents Chemother. 47:665-669.
19. White, D., J. Goldman, B. Demple, and S. Levy. 1997. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J. Bacteriol. 179:6122-6126.